Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Current Leases: 2015-2019

Historic Current Leases for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $192,290.

  • Outlook Therapeutics' Current Leases fell 11.60% to $181,585 in Q2 2020 from the same period last year, while for Jun 2020 it was $181,585, marking a year-over-year decrease of 11.60%. This contributed to the annual value of $192,290 for FY2019, which is 63.08% down from last year.
  • Per Outlook Therapeutics' latest filing, its Current Leases stood at $192,290 for FY2019, which was down 63.08% from $520,794 recorded in FY2018.
  • Outlook Therapeutics' Current Leases' 5-year high stood at $977,248 during FY2016, with a 5-year trough of $192,290 in FY2019.
  • In the last 3 years, Outlook Therapeutics' Current Leases had a median value of $341,120 in 2017 and averaged $351,401.
  • As far as peak fluctuations go, Outlook Therapeutics' Current Leases slumped by 65.09% in 2017, and later surged by 52.67% in 2018.
  • Outlook Therapeutics' Current Leases (Yearly) stood at $862,849 in 2015, then climbed by 13.26% to $977,248 in 2016, then crashed by 65.09% to $341,120 in 2017, then surged by 52.67% to $520,794 in 2018, then tumbled by 63.08% to $192,290 in 2019.